# Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease

> **NCT03566667** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Ole Frobert, MD, PhD** · enrollment: 1713 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Metoprolol
- **DRUG:** Standard care

## Key facts

- **NCT ID:** NCT03566667
- **Lead sponsor:** Ole Frobert, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-12
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-04-30
- **Target enrollment:** 1713 (ACTUAL)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03566667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03566667, "Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT03566667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*